Session 8 on Stem Cells

Stem Cell Basics

  • Stem Cells = undifferentiated cells of an organism that have the potential to differentiate into many “mature” cell types and can self-renew

  • Many factors that lead to differentiation, including:

    • Soluble factors (growth factors, cytokines)

    • Cell-cell contact/forced shapes

    • Epigenetic factors

  • Have the ability to self-renew

    • Constantly renew supply of stem cells without differentiation/getting old 

Stem Cells vs Body Cells

Stem Cells

  • Undifferentiated

    • No specialized functions

  • Self-renewal capabilities

Body Cells

  • Differentiated 

    • Specialized functions

  • May divide, cannot self-renew into stem cells 

Potency Levels

  • Totipotent: cells can differentiate into any of the 3 embryonic germ layers AND extraembryonic structures (e.g. placenta)

    • Most common in morula form of embryo (16-32 cells)

  • Pluripotent: cells can differentiate into any of the 3 embryonic germ layers ONLY 

    • Humans: blastocyst inner mass cells are pluripotent

Human Stem Cell Examples

  • Human Embryonic Stem Cells (hESCs): pluripotent

    • Extracted from human blastula inner cell mass

  • Mesenchymal Stem Cells (MSCs): multipotent 

    • Extracted from many sources, including bone marrow and umbilical cord

  • Neural Stem Cells (NSCs): multipotent

    • Extracted from embryonic/adult brains

Ethics issue + iPSCs 

  • Pluripotent cells = very good

    • Can only extract from embryos = very bad 

    • Embryos die in the process

  • Solution: induced pluripotent stem cells (iPSCs)

    • iPSCs are pluripotent

    • Revert body cells to pluripotent SCs w/ embryonic transcription factors

Application--ALS

  • Amyotrophic Lateral Sclerosis: neurodegenerative disease

  • Stem cells used to regenerate neural/glial cells

    • Other effects: anti-inflammatory, temporarily recover motor function, delay disease onset and progression

  • Commonly used cell lines

    • BM-MSCs

    • NSCs

  • Approved SC treatment: NeuroNata-R

Application: Diabetes

  • Diabetes: body doesn’t make enough insulin/use it appropriately

    • Type 1 Diabetes: insulin-making beta cells are killed by immune system

  • Stem cell-derived islet cell therapy to produce insulin 👉

  • Stem cells/pancreatic progenitors can also differentiate into beta cells

Application: SCI

  • Spinal Cord Injury: damage to any part of the spinal cord

    • Extreme back pain, weakness, numbness, inability to move

  • Stem cells can differentiate into neuronal or glial cells

    • mESCs/hESCs differentiate into neural progenitors, helped recover motor function

    • NSCs differentiate most directly

  • SC-derived neural progenitors had neuroprotective effects and regenerated axons

Application Burns

  • Stem cells aided in neo-angiogenesis 

    • Formation of new blood vessels

  • Treated mice regained body weight faster and experienced faster re-epidermal growth and a thicker epidermis than control mice

    • Inflicted with partial thickness burns (2nd degree burns)

Previous
Previous

Session 9 with Dr. Sophia Rangwala

Next
Next

Session 7 with Dr. Scott Klein